Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritization

mBio

Volumn 6, Issue 2, 2015, Pages

  Ianiri, Giuseppe ^a,b   Idnurm, Alexander ^a,c  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF MOLISE   (Italy)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; BASIDIOMYCETES; BIOINFORMATICS; CET1 GENE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ESSENTIAL GENE; FUNGAL STRAIN; FUNGAL VIABILITY; FUNGUS GROWTH; GENE IDENTIFICATION; GENETIC SIMILARITY; HAPLOIDY; HAPLOINSUFFICIENCY; HETEROZYGOTE; MEIOSIS; NONHUMAN; PRIORITY JOURNAL; RSA4 GENE; SPOROGENESIS; TRR1 GENE; DRUG DEVELOPMENT; FUNGAL GENE; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL GENETICS; MICROBIAL VIABILITY; MOLECULAR BIOLOGY; PROCEDURES;

ASCOMYCOTA; FILOBASIDIELLA NEOFORMANS; FUNGI; MAMMALIA;

ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; DRUG DISCOVERY; GENES, ESSENTIAL; GENES, FUNGAL; GENETICS, MICROBIAL; MICROBIAL VIABILITY; MOLECULAR BIOLOGY; MUTAGENESIS, INSERTIONAL;

EID: 84928794607     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02334-14     Document Type: Article

References (69)

1. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: human fungal infections. Sci TranslMed4:165rv113. http://dx.doi.org/10.1126/scitranslmed.3004404.
2. Casadevall A, Perfect J. 1998. Cryptococcus neoformans. ASM Press, Washington, DC.
3. Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A (ed). 2011. Cryptococcus: from human pathogen to model yeast. ASM Press, Washington, DC.
4. Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J. 2002. The direct cost and incidence of systemic fungal infections. Value Health 5:26–34. http://dx.doi.org/10.1046/j.1524-4733.2002.51108.x.
5. Barragan NC, Sorvillo F, Kuo T. 2014. Cryptococcosis-related deaths and associated medical conditions in the United States, 2000–2010. Mycoses 57:741–746. http://dx.doi.org/10.1111/myc.12238.
6. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, ChillerTM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525–530. http://dx.doi.org/10.1097/QAD.0b013e328322ffac.
7. Datta K, Bartlett KH, Baer R, Byrnes E, Galanis E, Heitman J, Hoang L, Leslie MJ, MacDougall L, Magill SS, Morshed MG, Marr KA, Cryptococcus gattii Working Group of the Pacific Northwest. 2009. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis 15:1185–1191. http://dx.doi.org/10.3201/eid1508.081384.
8. Byrnes EJ, III, Li W, Lewit Y, Ma H, Voelz K, Ren P, Carter DA, Chaturvedi V, Bildfell RJ, May RC, Heitman J. 2010. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 6:e1000850. http://dx.doi.org/10.1371/journal.ppat.1000850.
9. Lockhart SR, Iqbal N, Harris JR, Grossman NT, DeBess E, Wohrle R, Marsden-Haug N, Vugia DJ. 2013. Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates. PLoS One 8:e74737. http://dx.doi.org/10.1371/journal.pone.0074737.
10. Sionov E, Lee H, Chang YC, Kwon-Chung KJ. 2010. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog 6:e1000848. http://dx.doi.org/10.1371/journal.ppat.1000848.
11. Mondon P, Petter R, Amalfitano G, Luzzati R, Concia E, Polacheck I, Kwon-Chung KJ. 1999. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob Agents Chemother 43: 1856–1861.
12. Thompson JR, Douglas CM, Li W, Jue CK, Pramanik B, Yuan X, Rude TH, Toffaletti DL, Perfect JR, Kurtz M. 1999. A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function. J Bacteriol 181:444–453.
13. Firon A, d’Enfert C. 2002. Identifying essential genes in fungal pathogens of humans. Trends Microbiol 10:456–462. http://dx.doi.org/10.1016/S0966-842X(02)02442-3.
14. Carr PD, Tuckwell D, Hey PM, Simon L, d’Enfert C, Birch M, Oliver JD, Bromley MJ. 2010. The transposon impala is activated by low temperatures: use of a controlled transposition system to identify genes critical for viability of Aspergillus fumigatus. Eukaryot Cell 9:438–448. http://dx.doi.org/10.1128/EC.00324-09.
15. Hu W, Sillaots S, Lemieux S, Davison J, Kauffman S, Breton A, Linteau A, Xin C, Bowman J, Becker J, Jiang B, Roemer T. 2007. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathog 3:e24. http://dx.doi.org/10.1371/journal.ppat.0030024.
16. Firon A, Villalba F, Beffa R, d’Enfert C. 2003. Identification of essential genes in the human fungal pathogen Aspergillus fumigatus by transposon mutagenesis. Eukaryot Cell 2:247–255. http://dx.doi.org/10.1128/EC.2.2.247-255.2003.
17. Roemer T, Jiang B, Davison J, Ketela T, Veillette K, Breton A, Tandia F, Linteau A, Sillaots S, Marta C, Martel N, Veronneau S, Lemieux S, Kauffman S, Becker J, Storms R, Boone C, Bussey H. 2003. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol Microbiol 50:167–181. http://dx.doi.org/10.1046/j.1365-2958.2003.03697.x.
18. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, Bangham R, Benito R, Boeke JD, Bussey H, Chu AM, Connelly C, Davis K, Dietrich F, Dow SW, El Bakkoury M, Foury F, Friend SH, Gentalen E, Giaever G, Hegemann JH, Jones T, Laub M, Liao H, Liebundguth N, Lockhart DJ, Lucau-Danila A, Lussier M, M’Rabet N, Menard P, Mittmann M, Pai C, Rebischung C, Revuelta JL, Riles L, Roberts CJ, Ross-MacDonald P, Scherens B, Snyder M, Sookhai-Mahadeo S, Storms RK, Veronneau S, Voet M, Volckaert G, Ward TR, Wysocki R, Yen GS, Yu K, Zimmermann K, Philippsen P, Johnston M, Davis RW. 1999. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285: 901–906. http://dx.doi.org/10.1126/science.285.5429.901.
19. Dowell RD, Ryan O, Jansen A, Cheung D, Agarwala S, Danford T, Bernstein DA, Rolfe PA, Heisler LE, Chin B, Nislow C, Giaever G, Phillips PC, Fink GR, Gifford DK, Boone C. 2010. Genotype to phenotype: A complex problem. Science 328:469. http://dx.doi.org/10.1126/science.1189015.
20. Kim D-U, Hayles J, Kim D, Wood V, Park H-O, Won M, Yoo H-S, Duhig T, Nam M, Palmer G, Han S, Jeffery L, Baek S-T, Lee H, Shim YS, Lee M, Kim L, Heo K-S, Noh EJ, Lee A-R, Jang Y-J, Chung K-S, Choi S-J, Park J-Y, Park Y, Kim HM, Park S-K, Park H-J, Kang E-J, Kim HB, Kang H-S, Park H-M, Kim K, Song K, Song KB, Nurse P, Hoe K-L. 2010. Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. Nat Biotechnol 28:617–623. http://dx.doi.org/10.1038/nbt.1628.
21. Taylor JW, Berbee ML. 2006. Dating divergences in the fungal tree of life: review and new analyses. Mycologia 98:838–849. http://dx.doi.org/10.3852/mycologia.98.6.838.
22. Ianiri G, Idnurm A. 2014. Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritization, abstr 200, p 169. Book abstr, 12th Eur Conf Fungal Genet, Seville, Spain, 23 to 27 March 2014.
23. Janbon G, Ormerod KL, Paulet D, Byrnes EJ, Yadav V, Chatterjee G, Mullapudi N, Hon CC, Billmyre RB, Brunel F, Bahn YS, Chen W, Chen Y, Chow EW, Coppée JY, Floyd-Averette A, Gaillardin C, Gerik KJ, Goldberg J, Gonzalez-Hilarion S, Gujja S, Hamlin JL, Hsueh YP, Ianiri G, Jones S, Kodira CD, Kozubowski L, Lam W, Marra M, Mesner LD, Mieczkowski PA, Moyrand F, Nielsen K, Proux C, Rossignol T, Schein JE, Sun S, Wollschlaeger C, Wood IA, Zeng Q, Neuvéglise C, Newlon CS, Perfect JR, Lodge JK, Idnurm A, Stajich JE, Kronstad JW, Sanyal K, Heitman J, Fraser JA, Cuomo CA, Dietrich FS. 2014. Analysis of the genome and transcriptome of Cryptococcus neoformans var. grubii reveals complex RNA expression and microevolution leading to virulence attenuation. PLoS Genet 10:e1004261. http://dx.doi.org/10.1371/journal.pgen.1004261.
24. Allmang C, Petfalski E, Podtelejnikov A, Mann M, Tollervey D, Mitchell P. 1999. The yeast exosome and human PM-Scl are related complexes of 3'→5' exonucleases. Genes Dev 13:2148–2158. http://dx.doi.org/10.1101/gad.13.16.2148.
25. Missall TA, Lodge JK. 2005. Thioredoxin reductase is essential for viability in the fungal pathogen Cryptococcus neoformans. Eukaryot Cell 4:487–489. http://dx.doi.org/10.1128/EC.4.2.487-489.2005.
26. Mirande M, Waller JP. 1988. The yeast lysyl-tRNA synthetase gene. Evidence for general amino acid control of its expression and domain structure of the encoded protein. J Biol Chem 263:18443–18451.
27. Kirisako T, Ichimura Y, Okada H, Kabeya Y, Mizushima N, Yoshimori T, Ohsumi M, Takao T, Noda T, Ohsumi Y. 2000. The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J Cell Biol 151:263–276. http://dx.doi.org/10.1083/jcb.151.2.263.
28. Lang T, Schaeffeler E, Bernreuther D, Bredschneider M, Wolf DH, Thumm M. 1998. Aut2p and Aut7p, two novel microtubule-associated proteins are essential for delivery of autophagic vesicles to the vacuole. EMBO J 17:3597–3607. http://dx.doi.org/10.1093/emboj/17.13.3597.
29. Jonikas MC, Collins SR, Denic V, Oh E, Quan EM, Schmid V, Weibezahn J, Schwappach B, Walter P, Weissman JS, Schuldiner M. 2009. Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum. Science 323:1693–1697. http://dx.doi.org/10.1126/science.1167983.
30. Tsukamoto T, Shibagaki Y, Imajoh-Ohmi S, Murakoshi T, Suzuki M, Nakamura A, Gotoh H, Mizumoto K. 1997. Isolation and characterization of the yeast mRNA capping enzyme beta subunit gene encoding RNA 5'-triphosphatase, which is essential for cell viability. Biochem Biophys Res Commun 239:116–122. http://dx.doi.org/10.1006/bbrc.1997.7439.
31. Wills EA, Roberts IS, Del Poeta M, Rivera J, Casadevall A, Cox GM, Perfect JR. 2001. Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Mol Microbiol 40:610–620. http://dx.doi.org/10.1046/j.1365-2958.2001.02401.x.
32. Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, Noble SM. 2008. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135:174–188. http://dx.doi.org/10.1016/j.cell.2008.07.046.
33. Kim NK, Han K, Jung WH. 2010. Identification and functional characterization of a Cryptococcus neoformans UPC2 homolog. Mycobiology 38: 215–218. http://dx.doi.org/10.4489/MYCO.2010.38.3.215.
34. Lee DJ, Bahn YS, Kim HJ, Chung SY, Kang HA. 2015. Unraveling the novel structure and biosynthetic pathway of O-linked glycans in the Golgi apparatus of the human pathogenic yeast Cryptococcus neoformans. J Biol Chem 290:1861–1873. http://dx.doi.org/10.1074/jbc.M114.607705.
35. Costachel C, Coddeville B, Latgé JP, Fontaine T. 2005. Glycosylphosphatidylinositol-anchored fungal polysaccharide in Aspergillus fumigatus. J Biol Chem 280:39835–39842. http://dx.doi.org/10.1074/jbc.M510163200.
36. Ren L, McLean JR, Hazbun TR, Fields S, Vander Kooi C, Ohi MD, Gould KL. 2011. Systematic two-hybrid and comparative proteomic analyses reveal novel yeast pre-mRNA splicing factors connected to Prp19. PLoS One 6:e16719. http://dx.doi.org/10.1371/journal.pone.0016719.
37. González-Aguilera C, Tous C, Gómez-González B, Huertas P, Luna R, Aguilera A. 2008. The THP1-SAC3-SUS1-CDC31 complex works in transcription elongation-mRNA export preventing RNA-mediated genome instability. Mol Biol Cell 19:4310–4318. http://dx.doi.org/10.1091/mbc.E08-04-0355.
38. Nelson B, Kurischko C, Horecka J, Mody M, Nair P, Pratt L, Zougman A, McBroom LD, Hughes TR, Boone C, Luca FC. 2003. Ram: a conserved signaling network that regulates Ace2p transcriptional activity and polarized morphogenesis. Mol Biol Cell 14:3782–3803. http://dx.doi.org/10.1091/mbc.E03-01-0018.
39. Maerz S, Seiler S. 2010. Tales of RAM and MOR: NDR kinase signaling in fungal morphogenesis. Curr Opin Microbiol 13:663–671. http://dx.doi.org/10.1016/j.mib.2010.08.010.
40. Walton FJ, Heitman J, Idnurm A. 2006. Conserved elements of the RAM signaling pathway establish cell polarity in the basidiomycete Cryptococcus neoformans in a divergent fashion from other fungi. Mol Biol Cell 17: 3768–3780. http://dx.doi.org/10.1091/mbc.E06-02-0125.
41. Magditch DA, Liu TB, Xue C, Idnurm A. 2012. DNA mutations mediate microevolution between host-adapted forms of the pathogenic fungus Cryptococcus neoformans. PLoS Pathog 8:e1002936. http://dx.doi.org/10.1371/journal.ppat.1002936.
42. Dettmann A, Illgen J, März S, Schürg T, Fleissner A, Seiler S. 2012. The NDR kinase scaffold HYM1/MO25 is essential for MAK2 MAP kinase signaling in Neurospora crassa. PLoS Genet 8:e1002950. http://dx.doi.org/10.1371/journal.pgen.1002950.
43. Giaever G, Flaherty P, Kumm J, Proctor M, Nislow C, Jaramillo DF, Chu AM, Jordan MI, Arkin AP, Davis RW. 2004. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci U S A 101:793–798. http://dx.doi.org/10.1073/pnas.0307490100.
44. Roemer T, Xu D, Singh SB, Parish CA, Harris G, Wang H, Davies JE, Bills GF. 2011. Confronting the challenges of natural product-based antifungal discovery. Chem Biol 18:148–164. http://dx.doi.org/10.1016/j.chembiol.2011.01.009.
45. Butts A, Krysan DJ. 2012. Antifungal drug discovery: something old and something new. PLoS Pathog 8:e1002870. http://dx.doi.org/10.1371/journal.ppat.1002870.
46. Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. 2010. An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 9:719–727. http://dx.doi.org/10.1038/nrd3074.
47. Mukherjee PK, Sheehan DJ, Hitchcock CA, Ghannoum MA. 2005. Combination treatment of invasive fungal infections. Clin Microbiol Rev 18:163–194. http://dx.doi.org/10.1128/CMR.18.1.163-194.2005.
48. Idnurm A, Reedy JL, Nussbaum JC, Heitman J. 2004. Cryptococcus neoformans virulence gene discovery through insertional mutagenesis. Eukaryot Cell 3:420–429. http://dx.doi.org/10.1128/EC.3.2.420-429.2004.
49. Walton FJ, Idnurm A, Heitman J. 2005. Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans. Mol Microbiol 57:1381–1396. http://dx.doi.org/10.1111/j.1365-2958.2005.04779.x.
50. Idnurm A, Walton FJ, Floyd A, Reedy JL, Heitman J. 2009. Identification of ENA1 as a virulence gene of the human pathogenic fungus Cryptococcus neoformans through signature-tagged insertional mutagenesis. Eukaryot Cell 8:315–326. http://dx.doi.org/10.1128/EC.00375-08.
51. Kraus PR, Nichols CB, Heitman J. 2005. Calcium- and calcineurinindependent roles for calmodulin in Cryptococcus neoformans morphogenesis and high-temperature growth. Eukaryot Cell 4:1079–1087. http://dx.doi.org/10.1128/EC.4.6.1079-1087.2005.
52. Idnurm A. 2010. A tetrad analysis of the basidiomycete fungus Cryptococcus neoformans. Genetics 185:153–163. http://dx.doi.org/10.1534/genetics.109.113027.
53. Ni M, Feretzaki M, Li W, Floyd-Averette A, Mieczkowski P, Dietrich FS, Heitman J. 2013. Unisexual and heterosexual meiotic reproduction generate aneuploidy and phenotypic diversity de novo in the yeast Cryptococcus neoformans. PLoS Biol 11:e1001653. http://dx.doi.org/10.1371/journal.pbio.1001653.
54. Huang N, Lee I, Marcotte EM, Hurles ME. 2010. Characterising and predicting haploinsufficiency in the human genome. PLoS Genet 6:e1001154. http://dx.doi.org/10.1371/journal.pgen.1001154.
55. Giaever G, Shoemaker DD, Jones TW, Liang H, Winzeler EA, Astromoff A, Davis RW. 1999. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat Genet 21:278–283. http://dx.doi.org/10.1038/6791.
56. Xu D, Jiang B, Ketela T, Lemieux S, Veillette K, Martel N, Davison J, Sillaots S, Trosok S, Bachewich C, Bussey H, Youngman P, Roemer T. 2007. Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathog 3:e92. http://dx.doi.org/10.1371/journal.ppat.0030092.
57. Oh J, Fung E, Schlecht U, Davis RW, Giaever G, St Onge RP, Deutschbauer A, Nislow C. 2010. Gene annotation and drug target discovery in Candida albicans with a tagged transposon mutant collection. PLoS Pathog 6:e1001140. http://dx.doi.org/10.1371/journal.ppat.1001140.
58. Chan TF, Carvalho J, Riles L, Zheng XF. 2000. A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR). Proc Natl Acad Sci U S A 97:13227–13232. http://dx.doi.org/10.1073/pnas.240444197.
59. Wiley DJ, Catanuto P, Fontanesi F, Rios C, Sanchez N, Barrientos A, Verde F. 2008. Bot1p is required for mitochondrial translation, respiratory function, and normal cell morphology in the fission yeast Schizosaccharomyces pombe. Eukaryot Cell 7:619–629. http://dx.doi.org/10.1128/EC.00048-07.
60. Xue C, Tada Y, Dong X, Heitman J. 2007. The human fungal pathogen Cryptococcus can complete its sexual cycle during a pathogenic association with plants. Cell Host Microbe 1:263–273. http://dx.doi.org/10.1016/j.chom.2007.05.005.
61. Stajich JE, Harris T, Brunk BP, Brestelli J, Fischer S, Harb OS, Kissinger JC, Li W, Nayak V, Pinney DF, Stoeckert CJ, Jr, Roos DS. 2012. FungiDB: an integrated functional genomics database for fungi. Nucleic Acids Res 40:D675–D681. http://dx.doi.org/10.1093/nar/gkr918.
62. Braun BR, van het Hoog M, d’Enfert C, Martchenko M, Dungan J, Kuo A, Inglis DO, Uhl MA, Hogues H, Berriman M, Lorenz M, Levitin A, Oberholzer U, Bachewich C, Harcus D, Marcil A, Dignard D, Iouk T, Zito R, Frangeul L, Tekaia F, Rutherford K, Wang E, Munro CA, Bates S, Gow NA, Hoyer LL, Köhler G, Morschhäuser J, Newport G, Znaidi S, Raymond M, Turcotte B, Sherlock G, Costanzo M, Ihmels J, Berman J, Sanglard D, Agabian N, Mitchell AP, Johnson AD, Whiteway M, Nantel A. 2005. A human-cured annotation of the Candida albicans genome. PLoS Genet 1:36–57. http://dx.doi.org/10.1371/journal.pgen.0010001.
63. Abadio AK, Kioshima ES, Teixeira MM, Martins NF, Maigret B, Felipe MS. 2011. Comparative genomics allowed the identification of drug targets against human fungal pathogens. BMC Genomics 12:75. http://dx.doi.org/10.1186/1471-2164-12-75.
64. Becker JM, Kauffman SJ, Hauser M, Huang L, Lin M, Sillaots S, Jiang B, Xu D, Roemer T. 2010. Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model. Proc Natl Acad Sci U S A 107:22044–22049. http://dx.doi.org/10.1073/pnas.1009845107.
65. Colot HV, Park G, Turner GE, Ringelberg C, Crew CM, Litvinkova L, Weiss RL, Borkovich KA, Dunlap JC. 2006. A high-throughput gene knockout procedure for Neurospora reveals functions for multiple transcription factors. Proc Natl Acad Sci U S A 103:10352–10357. http://dx.doi.org/10.1073/pnas.0601456103.
66. Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol 175:1405–1411.
67. Nielsen K, Cox GM, Wang P, Toffaletti DL, Perfect JR, Heitman J. 2003. Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates. Infect Immun 71:4831–4841. http://dx.doi.org/10.1128/IAI.71.9.4831-4841.2003.
68. Potter CJ, Luo L. 2010. Splinkerette PCR for mapping transposable elements in Drosophila. PLoS One 5:e10168. http://dx.doi.org/10.1371/journal.pone.0010168.
69. Inglis DO, Skrzypek MS, Liaw E, Moktali V, Sherlock G, Stajich JE. 2014. Literature-based gene curation and proposed genetic nomenclature for cryptococcus. Eukaryot Cell 13:878–883. http://dx.doi.org/10.1128/EC.00083-14.